Printer Friendly

PHARMACEUTICAL RESOURCES ANNOUNCES PLAN TO RELAUNCH PREVIOUSLY APPROVED PRODUCTS IN FY'94 -- PAR SUBSIDIARY WILL BEGIN MARKETING METRONIDAZOLE

 SPRING VALLEY, N.Y., Nov. 5 /PRNewswire/ -- Pharmaceutical Resources, Inc. (NYSE: PRX) announced today that it plans to reintroduce several previously approved products in fiscal 1994. As part of that program, the company reported that its Par subsidiary is beginning to market Metronidazole 250mg and 500mg.
 Metronidazole is a generic formulation of Searle's Flagyl, an anti- bacterial. This product represents a previously approved ANDA which was placed on hold by the company pending the completion of an external audit by the company's independent regulatory consultant.
 Kenneth Sawyer, president and chief executive officer of Pharmaceutical Resources, commented, "The reintroduction of this product, the first of several planned for this year, demonstrates the company's ability to successfully bring products back into the market and expand the breadth of product line offered to our customers. We are satisfied that this product meets the stringent requirements of the FDA and matches the reliability of all products manufactured under the Par label today."
 Pharmaceutical Resources, Inc. is a holding company with subsidiaries that develop, manufacture and market a broad line of generic drugs.
 -0- 11/5/93
 /CONTACT: June Filingeri or Lisa Carlton of Morgen-Walke Associates, 212-850-5600/
 (PRX)


CO: Pharmaceutical Resources, Inc. ST: New York IN: MTC SU: PDT

LD -- NY004 -- 1053 11/05/93 06:30 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 5, 1993
Words:213
Previous Article:ONCOR, INC. REPORTS OPERATING RESULTS FOR THIRD QUARTER AND NINE MONTHS OF 1993
Next Article:FIELDCREST CANNON EXTENDS TENDER OFFER FOR AMOSKEAG COMPANY TO NOV. 24
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters